NRIX
Price
$11.57
Change
+$0.36 (+3.21%)
Updated
Jul 21, 11:12 AM (EDT)
Capitalization
857M
80 days until earnings call
RARE
Price
$26.19
Change
-$0.12 (-0.46%)
Updated
Jul 21, 12:00 PM (EDT)
Capitalization
2.49B
10 days until earnings call
Interact to see
Advertisement

NRIX vs RARE

Header iconNRIX vs RARE Comparison
Open Charts NRIX vs RAREBanner chart's image
Nurix Therapeutics
Price$11.57
Change+$0.36 (+3.21%)
Volume$299
Capitalization857M
Ultragenyx Pharmaceutical
Price$26.19
Change-$0.12 (-0.46%)
Volume$800
Capitalization2.49B
NRIX vs RARE Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. RARE commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and RARE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (NRIX: $11.21 vs. RARE: $26.31)
Brand notoriety: NRIX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 87% vs. RARE: 226%
Market capitalization -- NRIX: $857M vs. RARE: $2.49B
NRIX [@Biotechnology] is valued at $857M. RARE’s [@Biotechnology] market capitalization is $2.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 5 bearish.
  • RARE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RARE is a better buy in the short-term than NRIX.

Price Growth

NRIX (@Biotechnology) experienced а -9.89% price change this week, while RARE (@Biotechnology) price change was -10.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +37.94%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

RARE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($2.49B) has a higher market cap than NRIX($857M). RARE YTD gains are higher at: -37.461 vs. NRIX (-40.499). NRIX has higher annual earnings (EBITDA): -212.78M vs. RARE (-449.9M). RARE (494M) and NRIX (486M) have equal amount of cash in the bank . RARE has less debt than NRIX: RARE (38.3M) vs NRIX (51.9M). RARE has higher revenues than NRIX: RARE (591M) vs NRIX (88.4M).
NRIXRARENRIX / RARE
Capitalization857M2.49B34%
EBITDA-212.78M-449.9M47%
Gain YTD-40.499-37.461108%
P/E RatioN/AN/A-
Revenue88.4M591M15%
Total Cash486M494M98%
Total Debt51.9M38.3M136%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXRARE
RSI
ODDS (%)
Bearish Trend 6 days ago
86%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 6 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFOZX19.070.23
+1.22%
Alger Mid Cap Focus Z
NBRTX26.350.02
+0.08%
Neuberger Berman M/C Intrinsic Val Inst
SINOX38.760.01
+0.03%
ClearBridge Large Cap Value C
MLRMX9.89N/A
N/A
NYLI Winslow Large Cap Growth SIMPLE Cl
KDHCX52.78-0.16
-0.30%
DWS CROCI Equity Dividend C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-7.28%
KYMR - NRIX
67%
Closely correlated
-0.37%
DNLI - NRIX
60%
Loosely correlated
-3.65%
IDYA - NRIX
59%
Loosely correlated
-2.26%
RNA - NRIX
57%
Loosely correlated
-0.82%
BEAM - NRIX
55%
Loosely correlated
+1.47%
More